Abstract Title:

Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.

Abstract Source:

J Clin Rheumatol. 2010 Feb 2. Epub 2010 Feb 2. PMID: 20130483

Abstract Author(s):

Michael D Breglia, John D Carter

Article Affiliation:

From the *Department of Internal Medicine, College of Medicine, University of South Florida, Tampa, FL; and daggerDivision of Rheumatology, University of South Florida, Tampa, FL.

Abstract:

Osteoporosis is a major public health threat affecting millions of individuals in the United States. Bisphosphonate therapy is currently recognized as a first-line treatment of osteoporosis through the inhibition of osteoclast activity. Concerns have been raised about potential oversuppression of bone turnover and the development of atypical skeletal fragility associated with long-term use of bisphosphonates. A number of case reports in the literature have documented atypical insufficiency fractures in patients on long-term bisphosphonate therapy. This case outlines what we believe is the second documented atypical tibial insufficiency fracture in a patient on long-term bisphosphonate therapy, and highlights the need for increased awareness of atypical insufficiency fractures as well as the need for more data concerning the long-term effects of bisphosphonate therapy.

Study Type : Commentary
Additional Links

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.